Abstract
Exacerbated by the COVID-19 pandemic, there is increasing severity of emotional dysregulation and agitation among youth presenting across hospital systems. Proactive identification and timely implementation of evidence-based, nonpharmacologic, and etiologically based pharmacologic interventions are essential to address these challenges. In this Symposium, we review how different hospitals are approaching the development and implementation of standardized approaches to the evaluation and management of pediatric agitation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
